Gaurav Shah Insider Trading $RCKT ROCKET PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gaurav Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gaurav Shah. Gaurav Shah is CEO in ROCKET PHARMACEUTICALS, INC. ($RCKT) and President & CEO in ROCKET PHARMACEUTICALS, INC. ($RCKT) and See Remarks in ROCKET PHARMACEUTICALS, INC. ($RCKT).
Gaurav Shah in ROCKET PHARMACEUTICALS, INC.
Trading Symbol: RCKTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gaurav Shah: President & CEO, See Remarks
Holdings: 614,092 shares
Current Value: $1,043,956
Latest Transaction: Apr 01 2021
$RCKT Market Capitalization: $44.43M
$RCKT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Gaurav Shah in ROCKET PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 47.21 | 7,475 | 352,903 | 495,639 | 503.1 K to 495.6 K (-1.49 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 46.45 | 8,872 | 412,075 | 503,114 | 512 K to 503.1 K (-1.73 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.21 | 5,919 | 267,576 | 511,986 | 517.9 K to 512 K (-1.14 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.94 | 7,493 | 344,235 | 517,905 | 525.4 K to 517.9 K (-1.43 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Option Exercise | M | 1.69 | 75,880 | 128,237 | 0 | |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.06 | 23,003 | 1,036,557 | 525,398 | 548.4 K to 525.4 K (-4.19 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 44.24 | 61,350 | 2,714,320 | 548,401 | 609.8 K to 548.4 K (-10.06 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.59 | 3,000 | 136,770 | 609,751 | 612.8 K to 609.8 K (-0.49 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Buy | M | 1.69 | 75,880 | 128,237 | 612,751 | 536.9 K to 612.8 K (+14.13 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 44.34 | 8,505 | 377,105 | 536,871 | 545.4 K to 536.9 K (-1.56 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 43.86 | 48,732 | 2,137,152 | 545,376 | 594.1 K to 545.4 K (-8.20 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 42.80 | 8,667 | 370,906 | 594,108 | 602.8 K to 594.1 K (-1.44 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 41.80 | 19,984 | 835,329 | 614,092 | 634.1 K to 614.1 K (-3.15 %) |
Feb 08 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | A | 62.32 | 185,000 | 11,529,200 | 185,000 | |
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | M | 0.44 | 90,925 | 40,007 | 0 | |
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Payment of Exercise | F | 13.78 | 32,645 | 449,848 | 1,028,997 | 1.1 M to 1 M (-3.07 %) |
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Buy | M | 0.43 | 90,925 | 39,098 | 1,061,642 | 970.7 K to 1.1 M (+9.37 %) |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | M | 0.44 | 290,000 | 127,600 | 90,925 | |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Payment of Exercise | F | 20.15 | 6,233 | 125,595 | 970,717 | 977 K to 970.7 K (-0.64 %) |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Buy | M | 0.43 | 290,000 | 125,628 | 976,950 | 687 K to 977 K (+42.22 %) |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | A | 22.72 | 383,306 | 8,708,712 | 383,306 | |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 16.90 | 25,000 | 422,500 | 686,950 | 712 K to 687 K (-3.51 %) |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 17.28 | 24,900 | 430,272 | 711,950 | 736.9 K to 712 K (-3.38 %) |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 17.34 | 25,000 | 433,500 | 736,850 | 761.9 K to 736.9 K (-3.28 %) |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Option Exercise | A | 14.56 | 315,700 | 4,596,592 | 315,700 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Option Exercise | A | 18.75 | 395,000 | 7,406,250 | 395,000 |
Page: 1